Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane

Human Molecular Genetics

Volumn 7, Issue 2, 1998, Pages 217-226

  Deguen, Brigitte ^a,b   Mérel, Philippe ^a,e   Goutebroze, Laurence ^a,b   Giovannini, Marco ^a,b   Reggio, Hubert ^c   Arpin, Monique ^d   Thomas, Gilles ^a,b  

^a INSTITUT CURIE   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c CNRS   (France)

^d INSTITUT CURIE   (France)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYTOCHALASIN D; MERLIN; MUTANT PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; DNA TRANSFECTION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SOLUBILITY; TUMOR SUPPRESSOR GENE;

ACTINS; CELL MEMBRANE; CYTOCHALASIN D; CYTOSKELETON; DETERGENTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, NEUROFIBROMATOSIS 2; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, IMMUNOELECTRON; NEUROFIBROMIN 2; NOCODAZOLE; POINT MUTATION; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 0031964774     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.2.217     Document Type: Article

References (39)

1. Evans, D.G.R., Huson, S.M., Donnai, D., Neary, W., Blair, V., Newton, V. and Harris, R. A clinical study of type 2 neurofibromatosis (1992) Q. J. Med., 84, 603-618.
2. Rouleau, G.A., Mérel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., Pulst, S.M., Lenoir, G., Bijlsma, E., Fashold, R., Dumanski, J., de Jong, P., Parry, D., Eldrige, R., Aurias, A., Delattre, O. and Thomas, G. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature, 363, 515-521.
3. Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kley, N., Menon, A.G., Pulaski, K., Haase, V.H., Ambrose, C.M., Munroe, D., Bove, M.E., Haines, J.L., Martuza, R.L., MacDonald, M.E., Seizinger, B.R., Short, P., Buckler, A.J. and Gusella, J.F. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 72, 791-800.
4. MacCollin, M., Mohney, T., Trofatter, J., Wertelecki, W., Ramesh, V. and Gusella, J. (1993) DNA diagnosis of neurofibromatosis 2. JAMA, 270, 2316-2320.
5. MacCollin, M., Ramesh, V., Jacoby, L.B., Louis, D.N., Rubio, M.-P., Pulaski, K., Trofatter, J.A., Short, M.P., Bove, C., Eldridge, R., Parry, D.M. and Gusella, J.F. (1994) Mutational analysis of patients with neurofibromatosis 2. Am. J. Hum. Genet., 55, 314-320.
6. Mérel, P., Hoang-Xuan, K., Sanson, M., Bijlsma, E., Rouleau, G., Laurent-Puig, P., Pulst, S., Baser, M., Lenoir, G., Sterkers, J.-M., Philippen, J., Resche, F., Mautner, V.F., Fischer, G., Hulsebos, T., Aurias, A., Delattre, O. and Thomas, G. (1995) Screening for germ-line mutations in the NF2 gene. Genes Chrom. Cancer, 12, 117-127.
7. Bourn, D., Evans, G., Mason, S., Tekes, S., Trueman, L. and Strachan, T. (1995) Eleven novel mutations in the NF2 tumour suppressor gene. Hum. Genet., 95, 572-574.
8. Ruttledge, M.H., Andermann, A.A., Phelan, C.M., Claudio, J.O., Han, F.-Y., Chretien, N., Rangaratnam, S., MacCollin, M., Short, P., Parry, D., Michels, V., Riccardi, V.M., Weksberg, R., Kitamura, K., Bradburn, J.M., Hall, B.D., Propping, P. and Rouleau, G.A. (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am. J. Hum. Genet., 59, 331-342.
9. Parry, D.M., MacCollin, M.M., Kaiser-Kupfer, M.I., Pulaski, K., Nicholson, H.S., Bolesta, M., Eldridge, R. and Gusella, J.F. (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am. J. Hum. Genet., 59, 529-539.
10. Jacoby, L.B., MacCollin, M., Louis, D.N., Mohney, T., Rubio, M.-P., Pulaski, K., Trofatter, J.A., Kley, N., Seizinger, B., Ramesh, V. and Gusella, J.F. (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum. Mol. Genet., 3, 413-419.
11. Mérel, P., Hoang-Xuan, K., Sanson, M., Moreau-Aubry, A., Bijlsma, E.K., Lazaro, C., Moisan, J.P., Resche, F., Nishisho, I., Estivill, X., Delattre, J.Y., Poisson, M., Theillet, C., Hulsebos, T., Delattre, O. and Thomas, G. (1995) Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chrom. Cancer, 13, 211-216.
12. Lutchman, M. and Rouleau, G.A. (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res., 55, 2270-2274.
13. Tikoo, A., Varga, M., Ramesh, V., Gusella, J. and Maruta, H. (1994) An anti-ras function of neurofibromatosis type 2 gene product (NF2/merlin). J. Biol. Chem., 269, 23387-23390.
14. Sato, N., Funayama, N., Nagafuchi, A., Yonemura, S., Tsukita, Sa. and Tsukita, Sh. (1992) A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J. Cell Sci. 103, 131-143.
15. Arpin, M., Algrain, M. and Louvard, D. (1994) Membrane-actin microfilament connections: an increasing diversity of players related to band 4.1. Curr. Opin. Cell Biol., 6, 136-141.
16. Yonemura, S., Nagafuchi, A., Sato, N. and Tsukita, Sh. (1993) Concentration of an integral membrane protein. CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. J. Cell Biol., 120, 437-449.
17. Tsukita, Sa., Oishi, K., Sato, N., Sagira, J., Kawai, A. and Tsukita, Sh. (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cyloskeletons. J. Cell Biol., 126, 391-401.
18. Helander, T.S., Carpen, O., Turunen, O., Kovanen, P.E., Vaheri, A. and Timonen, T. (1996) ICAM-2 redistributed by ezrin as a target for killer cells. Nature, 382, 265-268.
19. Hirao, M., Sato, N., Kondo, T., Yonemura, S., Monden, M., Sasaki, T., Takai, Y., Tsukita, Sa. and Tsukita, Sh. (1996) Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol., 135, 37-51.
20. Turunen, O., Wahlström, T. and Vaheri, A. (1994) Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J. Cell Biol., 126, 1445-1453.
21. Pestonjamasp, K., Amieva, M.R., Strassel, C.P., Nauseef, W.M., Furthmayr, H. and Luna, E.J. (1995) Moesin, ezrin, and p205 are actin-binding proteins associated with neutrophil plasma membranes. Mol. Biol. Cell. 6, 247-259.
22. den Bakker, M.A., Tascilar, M., Riegman, P.H.J., Hekman, A.C.P., Boersma, W., Janssen, P.J.A., de Jong, T.A.W., Hendriks, W., van der Kwast. T.H. and Zwarthoff, B.C. (1995) Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am. J. Pathol. 147, 1339-1349.
23. Scherer, S.S. and Gutmann, D.H. (1996) Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J. Neurosci. Res., 46, 595-605.
24. Gonzalez-Agosti, C., Xu, L., Pinney, D., Beauchamp, R., Hobbs, W., Gusella, J. and Ramesh, V. (1996) The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene, 13, 1239-1247.
25. Huynh, D.P. and Pulst, S.-M. (1996) Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene, 13, 73-84.
26. Arakawa, H., Hayashi, N., Nagase, H., Ogawa, M. and Nakamura, Y. (1994) Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum. Mol. Genet., 3, 565-568.
27. Sekido, Y., Pass, H.I., Bader, S., Mew, D.J.Y., Christman, M.F., Gazdar, A.F. and Minna, J.D. (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res., 55, 1227-1231.
28. Bianchi, A.B., Mitsunaga, S.-I., Cheng, J.Q., Klein, W.M., Jhanwar, S.C., Seizinger, B., Kley, N., Klein-Szanto, A.J.P. and Testa, J.R. (1995) High frequency of inactivating mutations in the neurofibrormatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl Acad. Sci. USA. 92, 10854-10858.
29. Kluwe, L., Bayer, S., Baser, M.E., Hazim, W., Haase, W., Fünsterer, C. and Mautner, V.-F. (1996) Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes. Hum. Genet., 98, 534-538.
30. Algrain, M., Turunen, O., Vaheri, A., Louvard, D. and Arpin, M. (1993) Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J. Cell Biol., 120, 129-139.
31. Jasmin, B.J., Cartaud, J., Bornens, M. and Changeux, J.P. (1989) Golgi apparatus in chick skeletal muscle: changes in its distribution during end plate development and after denervation. Proc. Natl Acad. Sci. USA, 86, 7218-7222.
32. Schneider, C., Sutherland, R., Newman, R. and Greaves, M. (1982) Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9. J. Biol. Chem., 257, 8516-8522.
33. Griffiths, G., Hoflack, B., Simons, K., Mellman, I. and Kornfeld, S. (1988) The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell, 52, 329-341.
34. Louvard, D., Reggio, H. and Warren, G. (1982) Antibodies to the Golgi complex and the rough endoplasmic reticulum. J. Cell Biol., 92, 92-107.
35. Chaudhary, N. and Courvalin, J.-C. (1993) Stepwise reassembly of the nuclear envelope at the end of mitosis. J. Cell Biol., 122, 295-306.
36. Brewer, C.B. and Roth, M.G. (1991) A single amino acid change in the cytoplasmic domain alters the polarized delivery of influenza virus hemagglutinin. J. Cell Biol., 114, 413-421.
37. Chen, C. and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752.
38. Tokuyasu, K.T. (1973) A technique for ultracryotomy of cell suspensions and tissues. J. Cell Biol., 57, 551-565.
39. Griffiths, G., Simons, K., Warren, G. and Tokuyasu, K.T. (1983) Immunoelectron microscopy using thin, frozen sections: applications to studies of the intracellular transport of Semliki forest virus spike glycoproteins. Methods Enzymol., 96, 466-485.